Search

everythinglearnresearchcommunity

for

Search:↓

Glycyrrhizinic acid spray showed limited effectiveness in treating anogenital warts in HIV patients with low CD4 levels.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

New treatments for male hair loss are being explored to improve effectiveness and reduce side effects.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

New progesterone-based compounds can block male hormones.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

RUM-loaded SLN shows promise for treating acne and hair loss topically.

The new delivery method for dutasteride is more effective and has fewer side effects.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

Nanotechnology can improve cervical cancer treatment by targeting drugs better and reducing side effects.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

The treatment improved survival and controlled cancer spread but required managing side effects like rashes.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

AVT is highly conserved and may have antimicrobial properties.

A new treatment for hair loss shows promise with fewer side effects.